Here are the encouraging results of treatment of
#COVID19
patients with hydroxychloroquine worthy of further use without question
41
490
1K
Replies
@profvrr
Careful interpretation is needed 1) the 2 study cohorts are quite different in terms of age & case severity 2) d0 is admission date not disease onset- the treatment group may be further ahead in disease progression - in the pharynx, virus levels decline naturally after one week.
2
0
10
@profvrr
@profpathogen1
That is impressive. There are other treatments in pipeline. Reason for optimism and researchers that often compete are now working together.
0
0
5
@profvrr
Why didn't they put error bars on the figure? This preprint is going to get so much attention....
1
0
9
@profvrr
Arbidol, an approved anti-flu drug, which inhibits many other viruses including Ebola, Lassa, and coronas, is also showing encouraging results in studies in China:
1
3
14
@profvrr
Hey Italian,, Would you please put some remarks on these news. We love you, stay safe and keep strong!!!
1
0
1
@profvrr
I think this result is encouraging
#COVID19
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Co...
0
2
2
@profvrr
@bealelab
While hydroxychloroquine has yielded encouraging results in China/SK/France, this particular is not too trustworthy. See
0
0
1
@profvrr
@DrMFKearney
Encouraging, but note that all 6 patients excl'd from analysis were on treatment arm (4 for reasons suggesting growth of the infection). Effect size decreases if they are considered. I transcribed all data from Suppl. Table 1:
1
2
11
@profvrr
Virologists should read this post. Perhaps it can provide a little insight towards finding a cure. Perhaps it can help save lives.
1
0
0
@profvrr
Can you please just ask around for a minute before touting studies you clearly aren't qualified to assess?
We are in the midst of reviewing this pre-print, and I'm frankly flabbergasted to see it published virtually unchanged in a journal. A gross failure of peer review in my opinion.
17
192
433
1
0
7